Venture Capital

As OpenAI shelves its costly Sora video project, smaller firms like ReelTime tout a new path: efficiency over brute force. Is this the future of AI video?

A new wave of drug-free hair restoration combines ancient botanicals with FDA-cleared light therapy, challenging the chemical-reliant status quo.

A US firm is bringing embryo screening for chronic diseases to major IVF networks, sparking debate on the future of family planning and genetic health.

Renowned cardiac surgeon Dr. Robert C. Robbins brings his immense credibility to Linear Health Sciences, aiming to revolutionize patient care with a novel device.

New research shows high food prices are forcing U.S. consumers to cut beef, produce, and dairy, trading nutrition for affordability at the grocery aisle.

A new alliance between CollegeVine and Human Capital Education aims to solve AI's biggest campus challenge: turning powerful tech into real-world results.

Private firm ION Minerals now controls 280,000 acres across Texas and Canada, a bold move to dominate the future EV battery supply chain.

Exodigo's AI tech, now available to Texas agencies, promises to end costly underground surprises in public works, making projects safer and cheaper.

A startup's cooling tech, inspired by nuclear reactors, offers a 15% compute boost with zero water use, tackling the AI industry's energy crisis.

Interlink Electronics reports a wider Q4 loss but makes key moves in autonomous vehicle and robotic surgery sensors, signaling a major strategic pivot.

Austin startup Scalvy has secured major Series A funding to deploy its radical new power delivery platform for AI data centers and the energy grid.

A new partnership will embed real-world cell therapy manufacturing into NJIT's graduate program, aiming to fill a critical skills gap in the biotech industry.

The nation's top aesthetic clinic partners with BENEV to exclusively debut XTherma®, the first RF and cryogen device for pain-free skin rejuvenation.

After a $4.15B exit, Adam Wexler is back in music with The Hidden Jams, a non-profit aiming to replace algorithms with human-powered discovery.

As youth sports costs skyrocket, Winmark's Play It Again Sports enlists new pro athletes to champion its resale model and make sports accessible for all.

With a $2B war chest and a key simulation acquisition, Shield AI is accelerating the race to deploy AI pilots, reshaping the future of global defense.

Healthcare powerhouse Terri Cooper joins Morphic Medical's board, a strategic move to navigate clinical trials for its non-surgical RESET diabetes therapy.

Indian VLSI firm Ambit Semiconductors expands to Austin, Texas, aiming to bridge global talent and capture the future of AI and automotive chip design.

Freedom Trail Capital joins Kapor Capital and the NBA, revealing a new investment model where authentic influence is the ultimate unfair advantage.

A new RNA drug shows promise by reducing harmful belly fat while preserving muscle, but modest overall weight loss in early trials spooks investors.